Achieve Life Sciences Announces Board and Officer Changes
Ticker: ACHV · Form: 8-K · Filed: Dec 9, 2024 · CIK: 949858
| Field | Detail |
|---|---|
| Company | Achieve Life Sciences, Inc. (ACHV) |
| Form Type | 8-K |
| Filed Date | Dec 9, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $450,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, corporate-address, governance
TL;DR
Achieve Life Sciences is shaking up its leadership and moving its HQ to Canada.
AI Summary
Achieve Life Sciences, Inc. announced on December 5, 2024, a series of significant corporate actions. These include the election of new directors, the appointment of new officers, and changes to compensatory arrangements for certain officers. The company also reported a change in its business address to Vancouver, BC, Canada, indicating a potential shift in its operational base.
Why It Matters
Changes in board and officer composition can signal strategic shifts or governance adjustments within the company, potentially impacting future performance and direction.
Risk Assessment
Risk Level: medium — Changes in leadership and corporate structure can introduce uncertainty and potential execution risks.
Key Numbers
- 20241205 — Report Date (The filing date for the current report.)
- 033-80623 — SEC File Number (The SEC file number associated with the company.)
Key Players & Entities
- Achieve Life Sciences, Inc. (company) — Registrant
- December 5, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 95-4343413 (tax_id) — IRS Employer Identification No.
- 22722 29th Drive SE , Suite 100 Bothell , WA 98021 (address) — Previous Business Address
- 1040 West Georgia , Suite 1030 Vancouver , BC , Canada V6E 4H1 (address) — New Business Address
- ONCOGENEX PHARMACEUTICALS, INC. (company) — Former Company Name
- SONUS PHARMACEUTICALS INC (company) — Former Company Name
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors, but does not specify the names of newly elected or departing directors in the provided text.
Who are the newly appointed officers?
The filing mentions the appointment of certain officers but does not list their names or specific roles in the provided text.
What are the details of the compensatory arrangements for certain officers?
The filing notes changes to compensatory arrangements but does not provide specific details on these arrangements in the provided text.
What is the new primary business address of the company?
The new primary business address is 1040 West Georgia, Suite 1030, Vancouver, BC, Canada V6E 4H1.
When was the company formerly known as OncoGenex Pharmaceuticals, Inc.?
The date of the name change from OncoGenex Pharmaceuticals, Inc. was August 21, 2008.
Filing Stats: 1,037 words · 4 min read · ~3 pages · Grade level 12.3 · Accepted 2024-12-09 16:23:17
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ACHV The Nasdaq Stock Mar
- $450,000 — s: (i) an initial annual base salary of $450,000 per year, (ii) an annual discretionary
Filing Documents
- achv-20241205.htm (8-K) — 50KB
- 0000950170-24-134558.txt ( ) — 202KB
- achv-20241205.xsd (EX-101.SCH) — 50KB
- achv-20241205_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ACHIEVE LIFE SCIENCES, INC. Date: December 9, 2024 /s/ Richard Stewart Richard Stewart Chief Executive Officer (Principal Executive Officer)